A second-in-portfolio pharmaceutical product faced underperformance during their critical launch window. Vynamic was asked to conduct a 360° assessment of the brand strategy, business drivers, and tactical execution across all commercial functions to ensure a full understanding of root cause issues and missed opportunities. The goal was to identify overarching themes, recommend clear solutions, and establish a roadmap based on those prioritized recommendations.
A brand’s success in the critical launch window sets its performance trajectory. Market conditions and a company’s ability to work in a highly integrated fashion both factor into brand success. Knowing how critical that is to strategy and execution, Vynamic took an unbiased approach to understanding pre-launch, launch, and post-launch activities. Additionally, Vynamic assessed what factors were within organizational control so as to isolate true contributors to underperformance:
Establish a framework
Vynamic started by developing a brand performance framework anchored in a weighted scoring system for a cross-functional assessment tailored to the organization’s scope. As part of this, we partnered with the client team to complete stakeholder mapping, partner identification, comprehensive interview guides, and gain access to critical data sets.
Current state assessment
Vynamic conducted cross-functional interviews throughout the organization and with external partners. We analyzed and synthesized existing data/information to identify current state challenges and opportunities to address performance.
Plan of action
Based on the assessment findings, Vynamic developed an action plan to focus on addressing key cross-functional challenges and recommended adoption and investment of key growth levers to optimize the brand’s launch trajectory.
Stakeholder alignment and roll-out
Vynamic then built consensus and buy-in on the action plan and future cross-functional collaboration model.
Vynamic utilized the established framework to deliver assessment findings and data-driven recommendations that resulted in an action plan to focus the organization. The client accelerated a number of Vynamic’s key recommendations to maximize market opportunities. As a result, brand sales have increased and the client is equipped with not only key learnings, but also a reusable framework that can be applied elsewhere to ensure future launches are optimized regardless of the brand, functional scope, or launch timing.
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
Vynamic partnered with a top Life Sciences client for a multi-year omnichannel transformation, enhancing customer experience.
In the Medicare Advantage B2C market, learn how Vynamic streamlined touchpoints and cut costs while enhancing satisfaction
A global gene therapy client partnered with Vynamic to optimize its engagement with treatment centers in preparation for a product launch.